SPECIAL ISSUE - HUMAN GENETIC VARIATIONS IN OXIDATIVE DRUG-METABOLISM - INTRODUCTION

被引：32

作者：

SMITH, RL

机构：

来源：

关键词：

D O I：

10.3109/00498258609050244

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：361 / 365

页数：5

共 23 条

[1] METABOLISM OF DEBRISOQUINE IN RAT AND MAN
ANGELO, M
DRING, LG
LANCASTER, R
SMITH, RL
[J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1976, 4 (04) : 704 - 706
[2] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER
AYESH, R
IDLE, JR
RITCHIE, JC
CROTHERS, MJ
HETZEL, MR
[J]. NATURE, 1984, 312 (5990) : 169 - 170
[3] BARBEAU A, 1985, LANCET, V2, P1213
[4] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE
BERTILSSON, L
DENGLER, HJ
EICHELBAUM, M
SCHULZ, HU
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 153 - 155
[5] Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL
[6] DENGLER HJ, 1977, ARZNEIMITTEL-FORSCH, V27-2, P1836
[7] METABOLIC FATE OF AMPHETAMINE IN MAN AND OTHER SPECIES
DRING, LG
SMITH, RL
WILLIAMS, RT
[J]. BIOCHEMICAL JOURNAL, 1970, 116 (03) : 425 - &
[8] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
EICHELBAUM, M
SPANNBRUCKER, N
STEINCKE, B
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
[9] EICHELBAUM M, 1975, 6TH P INT C PHARM HE
[10] EICHELBAUM M, 1978, BIOL OXIDATION NITRO, P113